| Date | Time | Source | Headline | Symbol | Company |
| 05/24/2012 | 4:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/23/2012 | 2:39PM | Zacks | Lilly's GLP-1 Agonist Delivers - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/18/2012 | 12:10PM | Zacks | Revenues Skyrocket at Merged Alkermes - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/17/2012 | 5:46PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/17/2012 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/17/2012 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/17/2012 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/17/2012 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/17/2012 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/17/2012 | 5:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/17/2012 | 5:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/16/2012 | 4:13PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/16/2012 | 5:06AM | Zacks | Company News for May 16, 2012 - Corporate Summary | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/15/2012 | 6:18AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/15/2012 | 6:13AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/14/2012 | 6:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/08/2012 | 4:15PM | Business Wire | Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/07/2012 | 8:58AM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/03/2012 | 1:10PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2012 | 4:21PM | Business Wire | Amylin Pharmaceuticals to Present at Deutsche Bank 37th Annual Health Care Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/26/2012 | 7:18AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/26/2012 | 7:00AM | Business Wire | Amylin Pharmaceuticals Reports First Quarter 2012 Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/25/2012 | 2:53PM | Dow Jones News | Icahn: Suit Against Amylin Dropped After Talks With CEO | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/25/2012 | 2:03PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/20/2012 | 8:20AM | Marketwired | Large Pharmaceuticals Look to Acquire Smaller Biotech Companies to Drive Growth | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/19/2012 | 6:32PM | Dow Jones News | UPDATE: FDA Is Asked To Remove Novo Nordisk Diabetes Drug From Market | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/19/2012 | 4:15PM | Business Wire | Amylin Pharmaceuticals to Webcast First Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/19/2012 | 1:53PM | Dow Jones News | FDA Is Asked To Remove Novo Nordisk Diabetes Drug From Market | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/18/2012 | 9:31AM | PR Newswire (US) | Critical Alerts for Wal-Mart, FedEx, Coinstar, D.R. Horton, and Amylin Pharmaceuticals Released by Seven Summits Research | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/13/2012 | 4:44PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |